Summary Recommendations - ESRA
View all Procedures

New: Total Shoulder Arthroplasty

Summary Recommendations

PROSPECT provides clinicians with supporting arguments for and against the use of various interventions in postoperative pain based on published evidence and expert opinion. Clinicians must make judgments based upon the clinical circumstances and local regulations. At all times, local prescribing information for the drugs referred to must be consulted.

Total shoulder arthroplasty is frequently associated with moderate-to-severe postoperative pain (Gerbershagen 2013). A systematic review of the available evidence was therefore needed to identify and standardise effective perioperative strategies for pain management, with the aim of improving postoperative analgesia.

This review (Mrazek 2026) aimed to assess the literature and provide PROSPECT recommendations for optimal pain management after total shoulder arthroplasty.

The PROSPECT group performed the systematic review and formulated the recommendations using the unique PROSPECT methodology, available at https://esraeurope.org/prospect-methodology/. This methodology was first published in Joshi 2019 and updated in Joshi 2023.

EMBASE, MEDLINE, CENTRAL and Web of Science were searched from database inception to 2 June 2026 for randomised controlled trials (RCTs), systematic reviews, meta-analyses and umbrella reviews involving adults undergoing elective primary TSA. Eligible studies evaluated perioperative analgesic, anaesthetic or surgical interventions.

The primary outcome was postoperative pain, reported using a linear pain scale such as the Visual Analogue Scale or Numerical Rating Scale. Secondary outcomes included analgesic consumption and adverse events, where reported.

Of the studies identified by the literature search, 30 RCTs and 7 systematic reviews/meta-analyses met the inclusion criteria. The included studies were evaluated according to PROSPECT methodology. Recommendations were formulated after considering the benefits and adverse effects of the intervention in the clinical context of TSA with use of standard multimodal analgesia (paracetamol with an NSAID or COX-2-selective inhibitor).

This review is registered on PROSPERO: CRD420251156103.

Summary of recommendations and key evidence for pain management in patients undergoing primary TSA

Systemic (basic) analgesia

Paracetamol combined with an NSAID or COX-2-selective inhibitor is recommended, administered either preoperatively or intraoperatively and continued postoperatively, unless contraindicated

  • In accordance with PROSPECT methodology (Joshi 2023), RCTs representing basic analgesics (paracetamol, NSAIDs, COX-2 specific inhibitors) were not included in this updated review. These components are considered essential to all multimodal analgesic regimens.
A single intraoperative dose of dexamethasone 8–10 mg IV is recommended

  • The PROSPECT Working Group agreed that a single intraoperative dose of dexamethasone 8–10 mg IV could be considered part of basic analgesia because of its postoperative analgesic effects (Desai 2021).

Regional analgesia

Interscalene brachial plexus block with a single-bolus injection of long-acting local anaesthetic (bupivacaine or ropivacaine) is recommended

In case of contraindications or absence of expertise, local infiltration analgesia (with bupivacaine or ropivacaine) is a reasonable alternative.

Rescue analgesia

Opioids should be reserved for rescue analgesia

  • In accordance with PROSPECT methodology (Joshi 2023), RCTs investigating opioids were not included in this updated review.

COX, cyclooxygenase; IV, intravenous; NSAID, non-steroidal anti-inflammatory drug;
RCT, randomised controlled trial.

Analgesic interventions that are not recommended for pain management in patients undergoing primary TSA.

ISB, interscalene brachial plexus block; LIA, local infiltration analgesia.

*Non-selective NSAIDs or COX-2-selective inhibitors.

COX, cyclooxygenase; IV, intravenous; NSAID, non-steroidal anti-inflammatory drug.

PROSPECT recommendations for TSA – Infographic